694 related articles for article (PubMed ID: 18927524)
1. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
5. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
6. Trends in antihypertensive drug use among orally treated diabetic patients, in France between 1981 and 1992. Impact of guidelines and new drugs.
Maison P; Planchat-Fely P; Vauzelle-Kervroëdan F; Sermet C; Eschwège E
Diabetes Metab; 2001 Dec; 27(6):661-5. PubMed ID: 11852374
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
[TBL] [Abstract][Full Text] [Related]
10. [Hypertension in patients with diabetes].
Poulsen PL; Hansen KW; Gaede PH; Rossing P
Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
[TBL] [Abstract][Full Text] [Related]
11. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
[TBL] [Abstract][Full Text] [Related]
12. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
14. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
Guo QH; Pan CY; Qi WH; Lin SY;
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
[TBL] [Abstract][Full Text] [Related]
15. Long-term and strict blood pressure lowering by imidapril reverses left ventricular hypertrophy in patients with essential hypertension: an evaluation using a novel indicator of burden on the left ventricle.
Takahashi M; Minatoguchi S; Nishigaki K; Kawasaki M; Arai M; Uno Y; Fujiwara H
Hypertens Res; 2006 Feb; 29(2):89-94. PubMed ID: 16755142
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive drugs and fibrinolytic function.
Fogari R; Zoppi A
Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
[TBL] [Abstract][Full Text] [Related]
18. New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics.
Mogensen CE
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S15-20. PubMed ID: 16075028
[TBL] [Abstract][Full Text] [Related]
19. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
20. [Effect of long-term antihypertensive therapy on vaso-regulating function of the brachial artery in patients with arterial hypertension associated with type 2 diabetes mellitus].
Karpov RS; Koshel'skaia OA; Fal'kovskaia AIu; Ocheredko NA; Atroshenkov AV; Makarova EV
Ter Arkh; 2003; 75(11):56-60. PubMed ID: 14708444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
